Sito Bio(SZ:300583) Ge Long Hui·2025-12-05 08:37Group 1 - The company, Saito Bio (300583.SZ), announced adjustments to its fundraising investment plans to improve the efficiency of fund usage, with total investment adjusted to 229.3766 million yuan and the amount of raised funds adjusted to 130.2922 million yuan [1] - Part of the raised funds will be redirected to a new project, "Biological Synthesis Technology R&D and Industrialization Project," led by its wholly-owned subsidiary, Shandong Jinweiduo Pharmaceutical Co., Ltd. (referred to as "Jinweiduo") [1] - The new project involves an overall investment of 237.1312 million yuan, with 124.3688 million yuan of raised funds planned for investment, including interest of 2.7386 million yuan [1] Group 2 - The company plans to increase its investment in Jinweiduo by 100 million yuan using the raised funds and provide a loan of 24.3688 million yuan to Jinweiduo, with the remaining funds to be self-raised by Jinweiduo [1]